The $60 Billion Alternative Asset Most Investors Have Never Heard Of - Medical Finance and nvstIRA

In this podcast, Roberta Valentine, founder of nvstIRA, breaks down medical receivables finance — a $60B alternative asset class that most self-directed IRA investors have never considered. If you're tired of tenant headaches, syndication lockups, and single-digit returns on your investments, this is the conversation you need to hear.

What we cover:

- Why self-directed IRA investors feel "in control" but actually aren't - The #1 mistake people make when funding alternative investments - How medical receivables work (and why insurance-backed collateral is safer than you think) - PFD Capital's structure: $25K minimum, quarterly dividends, 12-month liquidity - Due diligence checklist for ANY alternative investment - Why private equity is outperforming real estate in 2025+

Connect with Roberta via text at 216-337-3231 or learn more at http://nvstira.com